Skip to content

"Comparison of Her2 and Ki67 as Prognostic Markers in Colorectal Cancer"

To study the utility of her2 and ki67 as immunohistochemical prognostic markers in comaprison to various histopathological parameters and TNM staging in colorecrtal carcinoma.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053165
Enrollment
60
Registered
2023-05-26
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K629- Disease of anus and rectum, unspecified

Interventions

Intervention1: Immunohistochemistry: Application of Immunohistochemical markers like Her2 and Ki67 on paraffin blocks of resected specimen of colorectal carcinoma patients for the duration or till the

Sponsors

Jawaharlal Nehru Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Already diagnosed as Colorectal carcinoma on histopathology. 2.All operated cases of Colorectal carcinoma. 3.Primary cases of Colorectal carcinoma without any history of previous treatment. 4.All patients with Colorectal carcinoma arising de novo.

Exclusion criteria

Exclusion criteria: 1.All Benign lesions of colon and rectum. 2.All the already treated cases of Colorectal Carcinoma. 3.All patients with Colorectal carcinoma where the cancer is arising as a result of recurrence. 4.Patients with no histological confirmation of Colorectal Carcinoma.

Design outcomes

Primary

MeasureTime frame
Prognostication of Her2 and Ki67 in colorectal Carcinoma patients.Timepoint: Primary outcome is expected to be achieved by the end of 2 years.

Secondary

MeasureTime frame
Achieving the desired sample size.Timepoint: Secondary out come is expected to be achieved at the end of 2 years.

Countries

India

Contacts

Public ContactSuhit Naseri

Jawaharlal Nehru Medical College, Sawangi

samarth21174@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026